People: Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

1,473.30INR
5:29am EST
Price Change (% chg)

Rs10.05 (+0.69%)
Prev Close
Rs1,463.25
Open
Rs1,490.15
Day's High
Rs1,495.00
Day's Low
Rs1,458.75
Volume
734,419
Avg. Vol
534,415
52-wk High
Rs1,495.00
52-wk Low
Rs845.20

Search Stocks

Summary

Name Age Since Current Position

Desh Gupta

Executive Chairman of the Board

Vinita Gupta

2013 Chief Executive Officer, Director

Kamal Sharma

2013 Executive Vice Chairman of the Board

Ramesh Swaminathan

2013 Chief Financial Officer

Maurice Chagnaud

2013 President - Europe and Head of Inhalation Strategy

Shakti Chakraborty

Group President - India Region Formulations & CIS

Debabrata Chakravorty

2013 President – Global Sourcing

Vinod Dhawan

Group President - AAMLA and Business Development

Alok Ghosh

2010 President - Technical Operations

Naresh Gupta

President - API & Global TB

Rajender Kamboj

President - Novel Drug Discovery & Development

Cyrus Karkaria

2010 President - Biotechnology

Divakar Kaza

2008 President - Human Resources

Sunil Makharia

2013 President - Finance

Paul McGarty

President of Lupin Pharmaceuticals Inc., USA

Sofia Mumtaz

2013 President - IPMG, New Products & Licencing

Rajvardhan Satam

2008 Compliance Officer, Company Secretary

Nilesh Gupta

2013 Managing Director, Executive Director

M. Gupta

2011 Executive Director

T Stevens

2013 Chief Corporate Development Officer

Dileep Choksi

64 2012 Non-Executive Independent Director

Vijay Kelkar

72 2010 Non-Executive Independent Director

K. Mada

80 Non-Executive Independent Director

R. Shah

83 2005 Non-Executive Independent Director

Richard Zahn

2010 Non-Executive Independent Director

Rajiv Pillai

IR Contact Officer

Biographies

Name Description

Desh Gupta

Dr. Desh Bandhu Gupta is Executive Chairman of the Board of Lupin Limited. He is an honorary Doctor of science (D.Sc.) with a master's degree in chemistry, Dr. Gupta, in his early career was an Associate Professor at Birla Institute of Science and Technology, Pilani, Rajasthan. Since 1968, when he founded the company, Dr Gupta has steered Lupin towards the forefront of India pharmaceuticals. In recent years, he has spearheaded the restructuring of Lupin's operations, and the research and innovation programs in new drug research and novel drug delivery systems.

Vinita Gupta

Mrs. Vinita Gupta is Chief Executive Officer, Director of Lupin Limited. She is graduate in pharmacy from the University of Mumbai and MBA from J L Kellog Graduate School of Management, Mrs. Vinita Gupta has been instrumental in Lupin's forays into the Advanced Markets and heads the Advanced Market business of the company in the markets of USA and Europe. Under her leadership, Lupin has emerged as a global generic player, especially in the US market in addition to becoming a strong player in the pediatric branded market. She is also a Chief Executive Officer Lupin Limitedon the Board of Lupin Ltd.

Kamal Sharma

Dr. Kamal K. Sharma, Ph.D., has been appointed as Executive Vice Chairman of the Board of Lupin Limited effective September 1, 2013. Dr. Kamal K. Sharma is a graduate in chemical engineering from the Indian institute of Technology (IIT), Kanpur, with a post-graduate diploma in industrial management from Jamnalal Bajaj Institute of management Studies, Mumbai, and a Ph.D in economics from IIT, Mumbai. He has also completed an advanced management program from Harvard Business School, Boston. In a career spanning more than three decades, Dr. Sharma has held a range of senior management positions managing projects, corporate development and general management in the pharmaceuticals and chemicals industries.

Ramesh Swaminathan

Mr. Ramesh Swaminathan is Chief Financial Officer of Lupin Limited. Previously he served as President - Finance & Planning of the company. He is a Chartered Accountant with over two decades experience, Mr. Swaminathan leads the Finance and Planning function. Prior to joining Lupin Mr. Swaminathan was with Henkel, Germany where he held corporate responsibilities as Regional Financial Controller for several countries across Central and Eastern Europe and the Middle East. Prior to that assignment, he was the CFO of Henkel India. He has also worked with companies such as VST Industries, the SPIC group and Standard Chartered Bank. Mr. Swaminathan is a member of the Institute of Chartered Management Accountants, UK and the Institute of Company Secretaries in India.

Maurice Chagnaud

Shakti Chakraborty

Mr. Shakti Chakraborty is Group President - India Region Formulations & CIS of Lupin Limited. He is a graduate in commerce and heads the India region business for finished products and has driven Lupin's entry in the lifestyle segment.

Debabrata Chakravorty

Vinod Dhawan

Alok Ghosh

Naresh Gupta

Rajender Kamboj

Cyrus Karkaria

Divakar Kaza

Sunil Makharia

Paul McGarty

Sofia Mumtaz

Rajvardhan Satam

Nilesh Gupta

Mr. Nilesh Gupta is Managing Director, Executive Director of Lupin Limited. He has been appointed as Managing Director of the Company effective September 1, 2013. He joined Lupin in 1996 and having led the Company's research, supply chain, manufacturing, quality and regulatory operations, was made Managing Director on 1st September, 2013. A Chemical Engineer from the University Department of Chemical Technology, Mumbai, and an MBA from the Wharton School, he has not only been responsible for transforming Lupin's research program and expanding the Company's manufacturing operations, but also been instrumental in formulating and executing the core strategy that has helped Lupin emerge as a global specialty pharma major.

M. Gupta

Mrs. M. D. Gupta is Executive Director of Lupin Limited.She is a graduate in arts, Mrs. Gupta is one of the promoters of the company with a wide business experience.

T Stevens

Dileep Choksi

Shri. Dileep C. Choksi is Non-Executive Independent Director of Lupin Limited., since October 23, 2012. Mr. Dileep C. Choksi is a leading Chartered Accountant, qualified lawyer and a Cost Accountant with over 35 years of experience. His areas of specialisation include tax planning and structuring for domestic and international clients, including expatriates, finalising collaborations and joint ventures, executive advisory and decision support, corporate restructuring with a focus on start-ups, turnaround and change management strategies and analysing tax impact of various instruments. Mr. Choksi advises some of India’s large business houses on various strategic matters and multinational clients on cross border structuring. He has set up C. C. Chokshi Advisors Pvt. Ltd., the activities of which aim to provide complete solutions for all business requirements.

Vijay Kelkar

Dr. Vijay Laxman Kelkar, Ph.D., is Non-Executive Independent Director of Lupin Limited. Dr. Vijay Kelkar is a Ph.D. from the University of California at Berkeley, M.S. from the University of Minnesota and B.S. from Pune University. He held senior positions in the Government of India and was Chairman/Member of several high-powered committees, councils, task forces, working groups, set up by different ministries and departments of the Government of India. Dr. Kelkar had delivered lectures at the Universities of California, Pennsylvania, Vanderbilt, Harvard and Cornell in the US and was visiting Professor at the South Asia Institute, Heidelberg University, West Germany and Center for Economic Development and Administration, Government of Nepal. He was a senior faculty member of the Administrative Staff College of India, Hyderabad and Instructor - Microeconomics, University of California, U.S.A. Dr. Kelkar has authored many books, publications and journals on micro and macroeconomics, reforms of union public sector, emerging challenges and on trade policies. In 2011, Dr. Kelkar was conferred ‘Padma Vibhushan’ for his distinguished and exemplary service to the nation.

K. Mada

Dr. K. U. Mada Ph.D. is Non-Executive Independent Director of Lupin Limited. Dr. K. U. Mada is an eminent economist and was a development banker. He holds a Ph.D. (Economics) degree from Bombay University and a certificate in financial management from Jamnalal Bajaj Institute, Mumbai. He taught Economics at Jai Hind College, Mumbai, for seven years. Thereafter, he worked for the Reserve Bank of India and Industrial Development Bank of India (IDBI) and held senior positions, including as Executive Director, IDBI, and a stint as chief of a bank. Dr. Mada was Chairman/Member of several committees constituted by lDBI/other financial institutions and the Government of India. He brought out books, including ‘A Journey through Development Banking (2005)’ and published articles in wellknown journals. He represented lDBI as Speaker/participant at several national and international conferences/seminars on economic, corporate and institutional affairs. He was a visiting faculty at management institutes. Dr. Mada was on the boards of corporate entities and all-India financial institutions, including the Management Development Institute, Gurgaon.

R. Shah

Mr. R. A. Shah is Non-Executive Independent Director of Lupin Limited. Mr. R. A. Shah is an eminent Solicitor and senior partner of M/s. Crawford Bayley & Company, a leading firm of Solicitors and Advocates in Mumbai. He specialises in a broad spectrum of Corporate Laws in general, with special focus on foreign investments, joint ventures, technology and license agreements, intellectual property rights, mergers and acquisitions, competition law and insider trading regulations. Mr. Shah is a member of the Managing Committee of Bombay Chamber of Commerce and Indo German Chamber of Commerce.

Richard Zahn

Mr. Richard A. Zahn is Non-Executive Independent Director of Lupin Limited. Mr. Richard Zahn is a B. S. (Business Administration) with Honors, Kansas State Teachers College, Kansas. He has completed Executive Education with Amos Tuck School, Dartmouth University, Harvard/MIT Program on Negotiation, The Wharton School, University of Pennsylvania, National Association of Corporate Directors - Certificate of Director Education. Mr. Zahn has also completed program in Executive Leadership, Cornell University. Mr. Richard is the Managing Partner of HMJ Global Partners, a corporate governance and not-for-profit public policy advisory group. With more than 30 years of experience in the biotechnology and pharmaceutical industries, he is an established leader and strategist in healthcare research and development, marketing management, managed care, and human resources. He is widely recognised as an insightful speaker on economic and policy issues. Mr. Richard was President of Schering Laboratories, U.S., Director, Schering Corporation and Corporate Vice President of Schering-Plough Corporation, a global researchbased company engaged in the discovery, development,manufacturing and marketing of pharmaceutical, biotechnology and healthcare prescription pharmaceutical marketing arm for Schering-Plough. Mr. Richard spent 20 years at Johnson & Johnson. Mr. Richard has focused his efforts on rural economic development and public policy. He has received several awards for his devoted work towards various organisations and charities with particular focus on health care and minority issues.

Rajiv Pillai

Search Stocks